Today’s Stock Market in 2-Minutes
August 7, 2026
-
-
SEALSQ’s SEALQuantum Sovereign Quantum Vertical Stack Interconnects Its Growing Ecosystem as $200 Million SEALQuantum.com Initiative Enters Second Phase of Deployment in September
August 7, 2026
-
HeartCore Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
August 7, 2026
-
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 7, 2026
-
Top News
- AEye to Participate in J.P. Morgan Auto Conference August 7, 2026
- SoCalGas Board of Directors Approves Retirement of All Outstanding Shares of Preferred Stock August 7, 2026
- Castor Maritime Inc. Announces Joint Venture and Contribution of the M/V Magic Starlight August 7, 2026
- Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million August 7, 2026
Sequire Spotlight Presents: Gevo (GEVO) – Drop-In Jet Fuel From Renewables Poised for Scale
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Popular Reads
-
Unprecedented Opportunity, Environmentally Friendly Technology
Recently uplisted to NASDAQ, Vivakor, Inc. (Nasdaq: VIVK) is a socially responsible operator, primarily focused on soil remediation and the extraction of hydrocarbons, such as oil, from properties contaminated with heavy crude oil and other hydrocarbon-based substances. Once the contaminated soil is cleaned using Vivakor’s patented remediation processes, the reclaimed hydrocarbons can be sold and […]
February 16, 2022
-
Axe Compute Secures Over $1.3 Billion in Global AI Infrastructure Customer Contracts
July 22, 2026
-
HeartCore Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
NEW YORK and TOKYO, Aug. 07, 2026 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, has entered into an agreement to transfer its entire 51% equity interest in HeartCore Luvina Vietnam Company Limited (“HCLV”), the Company’s Vietnam-based software development joint venture, to Luvina Software Joint […]
August 7, 2026
-
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC, or other drug-related review matters. Remaining item relates to manufacturer certification for a luer lock vial already used in three FDA-approved ANDA products with 11.9 million units shipped over the past 12 months without complaints, returns, adverse events, or recalls. […]
August 7, 2026
News
-
Today’s Stock Market in 2-Minutes
August 7, 2026
-
SEALSQ’s SEALQuantum Sovereign Quantum Vertical Stack Interconnects Its Growing Ecosystem as $200 Million SEALQuantum.com Initiative Enters Second Phase of Deployment in September
August 7, 2026
-
SoCalGas Board of Directors Approves Retirement of All Outstanding Shares of Preferred Stock
August 7, 2026
-
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
August 7, 2026
-
HeartCore Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
August 7, 2026
-
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 7, 2026
-
AEye to Participate in J.P. Morgan Auto Conference
August 7, 2026
-
Kiora Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 7, 2026